Keynote speaker
Professor, Dana-Farber Cancer Institute, Harvard Medical School
A. Thomas Look, Dana-Farber Cancer Institute, Harvard Medical School, gave a keynote at InnoPharm 2026: 2nd Edition of Innovations in Pharma R&D (Boston, United States of America, 2–4 Nov 2026) in the session “KAT6A/B Inhibitor Transcriptionally Upregulates GD2 to Sensitize Neuroblastoma Cells to Targeted Immunotherapy”.
2–4 Nov 2026Boston, United States of America
Professor, Colorado State University, Fort Collins, CO
Professor, University of California
Professor, Brigham and Women’s Hospital, Harvard Medical School
Founding Director & Core Faculty, Wyss Institute at Harvard University
Professor, Virginia Polytechnic Institute & State University
Professor, Stanford University
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by A. Thomas Look, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].